| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 08/11/2010 | EP2215068A1 Antidiabetic tricyclic compounds |
| 08/11/2010 | EP1797051B1 Benzoxazine and quinoxaline derivatives and uses |
| 08/11/2010 | EP1484301B1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE |
| 08/10/2010 | US7772285 Benzophenone derivatives or salts thereof |
| 08/10/2010 | US7772229 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 08/10/2010 | US7772225 N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions |
| 08/10/2010 | US7772190 E.g., isobutyl N-methyl-N-trimethylallophanoyl-L-alanyl-D-lactate; using parasiticides and nematocides in medicine and veterinary medicine; productive and breeding animals; foods and feeds |
| 08/10/2010 | CA2559397C Substituted morpholine and thiomorpholine derivatives |
| 08/05/2010 | WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof |
| 08/05/2010 | WO2010085978A1 Process for the preparation of efavirenz |
| 08/05/2010 | WO2010042867A3 Activators of human pyruvate kinase |
| 08/05/2010 | WO2010031708A3 Ortho-aminoanilides for the treatment of cancer |
| 08/05/2010 | US20100197680 Lactam-substituted dicarboxylic acids and use thereof |
| 08/05/2010 | US20100197676 5-Substituted-2-Phenylamino Benzamides as Mek Inhibitors |
| 08/05/2010 | US20100197675 Cyclic urea and carbamate inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
| 08/05/2010 | US20100197640 Novel sulfamoyl-phenyl-ureido compounds and their use as medicament |
| 08/05/2010 | US20100197564 Diaryl morpholines as cb1 modulators |
| 08/05/2010 | CA2750452A1 N-acyl anthranilic acid derivative or salt thereof |
| 08/04/2010 | EP1392660B1 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 08/04/2010 | CN101796039A Phenylacetic acid compound |
| 08/03/2010 | US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/03/2010 | US7767668 Micronized tanaproget, compositions, and methods of preparing the same |
| 08/03/2010 | CA2204748C Use of dioxomorpholines for combating endoparasites, new dioxomorpholines and processes for their preparation |
| 07/29/2010 | WO2010042925A3 Compositions and methods for treating alcohol use disorders, pain and other diseases |
| 07/29/2010 | US20100190764 Novel compounds |
| 07/29/2010 | US20100190756 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 07/28/2010 | EP2209770A1 Method of making ketals and acetals |
| 07/27/2010 | US7763657 such as N-{-4-[3-(4-t-butylbenzyl)ureidomethyl]-2-vinylphenyl}methanesulfonamide, used as analgesics, and for treating psoriasis, pruritus, asthma, chronic obstructive pulmonary disease, urinary incontinence, inflammatory bowel disease, tinnitus and ischemia |
| 07/27/2010 | US7763649 Treating cardiac arrhythmia and/or cancerous and pre-cancerous cells by administering specific synthetic carotenoid analogs or derivatives either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation |
| 07/22/2010 | WO2010083441A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | WO2010082627A1 Process for producing 2-hydroxymethylmorpholine salt |
| 07/22/2010 | US20100184974 Protease Inhibitors |
| 07/22/2010 | US20100184768 Isoprenyl Compounds and Methods Thereof |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100181527 Nitroxide containing electrode materials for secondary batteries |
| 07/22/2010 | DE102008003826B4 Verwendung von Salzen als Korrosionsinhibitoren mit erhöhter biologischer Abbaubarkeit und verminderter Toxizität und diese Salze Use of salts as corrosion inhibitors having increased biodegradability, and reduced toxicity, and these salts |
| 07/22/2010 | CA2747835A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/21/2010 | EP2208728A1 Heterocyclic derivative having inhibitory activity on type-i 11 -hydroxysteroid dehydrogenase |
| 07/21/2010 | EP1613621B1 Prostaglandin analogs as ep4 receptor agonists |
| 07/21/2010 | EP1259243B2 Bupropion metabolites and methods of their synthesis and use |
| 07/21/2010 | CN101781267A Method for producing acylamide compounds |
| 07/15/2010 | US20100179109 Renin inhibitors |
| 07/14/2010 | EP2206706A2 Method for producing acylamide compounds |
| 07/14/2010 | EP2206705A1 Method for manufacturing benzomorpholine derivatives through hydration of o-nitrophenoxycarbonyl compounds |
| 07/14/2010 | EP2205559A1 Renin inhibitors |
| 07/13/2010 | US7754882 such as Cis-6-Phenyl-9-(3-piperidin-1-yl-propoxy)-1,2,3,5,6,10b-hexahydro-pyrrolo [2,1a]isoquinoline, used as histamine H3 receptor and serotonin transporter modulators useful in the treatment of depression |
| 07/13/2010 | US7754737 such as N-(1-amino-3-cyclohexylpropan-2-yl)-3-(1-hydroxy-1-phenylpentyl)piperidine-1-carboxamide, used in the treatment of cardiovascular, metabolic and cognitive disorders, aldosteronism, hypertension and anxiety |
| 07/13/2010 | CA2567776C Vasopressin v1a antagonists |
| 07/08/2010 | WO2010078103A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 07/08/2010 | WO2010028051A3 Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors |
| 07/08/2010 | US20100174067 Method for Producing Scopine Esters |
| 07/08/2010 | US20100173889 Substituted Pyrimidine and Triazine Compounds |
| 07/08/2010 | US20100173823 Alpha2c adrenoreceptor agonists |
| 07/07/2010 | EP1597244B1 Ethynyl derivatives serving as factor xa inhibitors |
| 07/07/2010 | EP1491537B1 Hydroxymorpholinone derivative and medicinal use thereof |
| 07/07/2010 | CN101768131A Method for hydrogenating o-nitryl phenoxyl carbonyl compound to prepare a derivative of benzo morpholines |
| 07/06/2010 | US7750032 Compounds and compositions as PPAR modulators |
| 07/06/2010 | US7750004 Apoptosis promoters |
| 07/06/2010 | US7749999 Alpha-ketoamides and derivatives thereof |
| 07/01/2010 | WO2010073254A2 Process for preparing efavirenz polymorph |
| 07/01/2010 | US20100168422 Methods and intermediates useful in the synthesis of hexahydrofuro [2,3-b]furan-3-ol |
| 07/01/2010 | US20100168112 2-Substituted and 4-substituted aryl nitrone compounds |
| 07/01/2010 | US20100168094 Modulators of cystic fibrosis transmembrane conductance regulator |
| 07/01/2010 | US20100168080 Novel compounds useful as cc chemokine receptor ligands |
| 06/29/2010 | US7745663 mitogen-activated protein kinase inhibitors such as 3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5(2-hydroxy-ethoxymethyl)-benzamide, used to treat proliferative diseases, for example, cancers, psoriasis, restenosis, autoimmune diseases and atherosclerosis |
| 06/29/2010 | US7745646 enzyme inhibitors of phosphodiesterase 4; antiinflammatory agent for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines |
| 06/29/2010 | US7745621 Long acting bronchodilators for the treatment of respiratory diseases |
| 06/29/2010 | US7745439 Indene derivatives and process for the preparation thereof |
| 06/29/2010 | US7745438 beta -secretase inhibitors such as N-{(1S,2S)-1-(3,5-Difluorobenzyl)-2-[(3R,5S,6R)-6-(2,2-dimethylpropoxy)-5-methylmorpholin-3-yl]-2-hydroxyethyl}-acetamide, used for the treatment of neurodegenerative disorders such as Alzheimer's disease |
| 06/29/2010 | US7744910 Compounds and compositions for delivering active agents |
| 06/24/2010 | WO2010070365A1 1,3-heterocycles condensed with monoterpene skeleton, their use and pharmaceutical compositions comprising such compounds |
| 06/24/2010 | US20100160327 Modified Malonate Derivatives |
| 06/24/2010 | US20100160326 Pest control agent containing novel pyridyl-methanamine derivative or salt thereof |
| 06/24/2010 | US20100160285 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease |
| 06/24/2010 | US20100160247 Synthesis of deuterated morpholine derivatives |
| 06/24/2010 | US20100158798 FP-Pocket-Binding Effectors and Methods for Using the Same to Modulate Telomerase Activity |
| 06/24/2010 | DE102008062906A1 Verfahren zur Herstellung von Benzomorpholinderivaten durch Hydrierung von o-Nitrophenoxycarbonylverbindungen Process for the preparation of benzomorpholine derivatives by hydrogenation of o-Nitrophenoxycarbonylverbindungen |
| 06/24/2010 | DE102008062905A1 Verfahren zur Herstellung von Acylamid-Verbindungen A process for preparing compounds of acylamide |
| 06/23/2010 | EP2197859A1 Method of producing benzoxazinone-based compound |
| 06/23/2010 | EP2197832A1 Novel aryl potassium channel blockers and uses thereof |
| 06/23/2010 | CN101747288A Monocyclic benzoxazine intermediate with low viscosity and a plurality of functional groups and synthesis method thereof |
| 06/22/2010 | US7741323 6-methoxy-1-(trans-methylimino-N-oxy)-3-phenyl-1H-indene-2-carboxylate ethyl ester, used for selectively modulating the activities of peroxisome proliferator activated receptors; excellent effect in lowering both blood glucose and insulin levels; side effect reduction |
| 06/22/2010 | US7740693 E.g., 1-(p-toluenesulfonyl)-3-[2-(4-oxo-4H-benzo[d]-[3.1]oxazine-2-yl)-phenyl]urea; fluorine-free; marking currency, passports, chip cards, checks, check cards, credit cards, debit cards, identity cards, certificates, bank notes, and postal items |
| 06/22/2010 | CA2536926C Novel method for synthesizing esters of n-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril |
| 06/17/2010 | WO2010068881A1 Novel benzodioxane and benzoxazine derivatives useful as cc chemokine receptor ligands |
| 06/17/2010 | WO2010067078A2 3,6-disubstituted xanthylium salts as medicaments |
| 06/17/2010 | US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 06/17/2010 | CA2745203A1 3,6-disubstituted xanthylium salts |
| 06/16/2010 | EP2195395A2 New organic fluorescent sulfonyl ureido benzoxazinone pigments |
| 06/16/2010 | EP2195330A1 Method and agent for refolding proteins |
| 06/16/2010 | CN1989141B Bicyclic heterocycles as HIV integrase inhibitors |
| 06/16/2010 | CN1805944B Cyclic hydroxylamine as psychoactive compounds |
| 06/16/2010 | CN101743233A Benzoxazine containing compositions of matter and curable compositions made therewith |
| 06/16/2010 | CN101735166A Novel medicaments for the treatment of chronic obstructive pulmonary diseases |
| 06/16/2010 | CN101735165A Preparation method of 3-morpholone |
| 06/15/2010 | US7737140 Therapeutic compounds |
| 06/15/2010 | US7737139 useful in inhibiting the chernotactic activation of neutrophils, induced by the interaction of Interleukin-8 (IL-8) with chemokine membrane receptors |
| 06/15/2010 | US7737135 (2S)-2-[[4'-(methylsulfonyl)-3',5-bis(trifluoromethyl)[1,1'-biphenyl]-2-yl]oxy]-propanoic acid for example; asthma or rhinitis; orphan receptor CRTH2 modulators, prostaglandin D2 is a ligand of CRTH2 |
| 06/10/2010 | WO2010065717A1 Morpholinone compounds as factor ixa inhibitors |
| 06/10/2010 | US20100144727 Oxazolidine and Morpholine Carboxamide Derivatives as P2X7 Modulators |